Presentation TCT 2017 FAME 2: 3-Year Clinical and Cost-effectiveness Outcomes of FFR-Guided PCI in Patients With Coronary Artery Disease Presenter: Gregg W. Stone, William F. Fearon November 02, 2017
Presentation TCT 2017 ORBITA: A Randomized, Sham-Controlled Trial of PCI in Patients With Coronary Artery Disease Presenter: Gregg W. Stone, Rasha Al-Lamee November 02, 2017
News Opinion Editor's Corner TCT 2017 Live From Denver: TCT 2017, Day Four Shelley Wood November 02, 2017
Presentation TCT 2017 PREVAIL: 5-Year Outcomes From a Randomized Trial of Left Atrial Appendage Closure vs Medical Therapy in Patients With Nonvalvular Atrial Fibrillation Presenter: Saibal Kar November 02, 2017
News Conference News TCT 2017 ORBITA: PCI Offers No Symptom Improvement Over Sham Procedure Michael O'Riordan November 02, 2017
Presentation TCT 2017 RESOLVE/SAVORY: Critique and Unanswered Questions Presenter: David J. Moliterno, Vinod H. Thourani, Mohamed Abdel-Wahab November 01, 2017
Presentation TCT 2017 RESOLVE/SAVORY: Topline Findings and Practice Implications Presenter: David J. Moliterno, Vinod H. Thourani, Lars Sondergaard November 01, 2017
Presentation TCT 2017 REDUCE: A Randomized Trial of 3-Month vs 12-Month DAPT After Implantation of a Bioabsorbable Polymer-Based Metallic DES With a Luminal CD34+ Antibody Coating in Patients With ACS Presenter: Robert A. Harrington, Gregg W. Stone, Harry Suryapranata November 01, 2017
News Opinion Editor's Corner TCT 2017 Live From Denver: TCT 2017, Day Three Shelley Wood November 01, 2017
Presentation TCT 2017 DAPT STEMI: A Randomized Trial of 6-Month vs 12-Month DAPT After DES Implantation in STEMI Presenter: Robert A. Harrington, Gregg W. Stone, Elvin Kedhi November 01, 2017
Presentation TCT 2017 SENIOR: A Randomized Trial of a Bioabsorbable Polymer-Based Metallic DES vs a BMS With Short DAPT in Patients With Coronary Artery Disease Older Than 75 Years Presenter: Robert A. Harrington, Gregg W. Stone, Olivier Varenne November 01, 2017
News Conference News TCT 2017 Long-term Absorb BVS Data Continue to Disappoint Michael O'Riordan October 31, 2017
Presentation TCT 2017 PARTNER 2A and SAPIEN 3 Cost-effectiveness: Cost-effectiveness of TAVR vs SAVR in Intermediate-Risk Patients With Aortic Stenosis Presenter: Patrick W. Serruys, David J. Cohen October 31, 2017
Presentation TCT 2017 ABSORB IV: 30-Day Outcomes From a Randomized Trial of a Bioresorbable Scaffold vs a Metallic DES in Patients With Coronary Artery Disease Presenter: Patrick W. Serruys, Gregg W. Stone October 31, 2017
Presentation TCT 2017 ABSORB III: 3-Year Outcomes From a Randomized Trial of a Bioresorbable Scaffold vs a Metallic DES in Patients With Coronary Artery Disease Presenter: Patrick W. Serruys, Stephen G. Ellis October 31, 2017
Presentation TCT 2017 DKCRUSH-V: A Randomized Trial of Double Kissing Crush vs Provisional Stenting for Treatment of Distal Left Main Bifurcation Lesions Presenter: Gregg W. Stone, Shao-Liang Chen October 30, 2017
Presentation TCT 2017 EXCEL QOL: Quality of Life After PCI vs CABG in Left Main Coronary Artery Disease Presenter: Gregg W. Stone, Suzanne J. Baron October 30, 2017
Presentation TCT 2017 CULPRIT-SHOCK: A Randomized Trial of Multivessel PCI in Cardiogenic Shock Presenter: Gregg W. Stone, Holger Thiele October 30, 2017
News Opinion Off Script TCT 2017 Off Script: Welcome to TCT 2017 in the Mile High City Kwan S. Lee October 29, 2017